Last reviewed · How we verify
NCT06179342
Multiple Breath Washout as a Method for Diagnosing Lung Diseases
trial testing Multiple-Breath-Washout in Pulmonary Fibrosis in 90 participants. Completed in 1 March 2024.
1 March 2024
Quick facts
| Lead sponsor | Wissenschaftliches Institut Bethanien e.V |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 21 June 2021 |
| Primary completion | 1 March 2024 |
| Estimated completion | 1 March 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Multiple-Breath-Washout
Conditions studied
- Pulmonary Fibrosis — all drugs for Pulmonary Fibrosis →
- COPD — all drugs for COPD →
- Asthma — all drugs for Asthma →
Sponsor
Wissenschaftliches Institut Bethanien e.V
Who can join
Eligibility, any sex, with Pulmonary Fibrosis or COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of the new multiple-breath washout method (ndd Medizintechnik Zürich, Trueflow™/Truecheck™) with established methods of lung function diagnostics in patients with idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, asthma and cardiopulmonary healthy individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06179342
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Fibrosis
Currently open trials in the same condition.
- NCT07464132 — Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases · Phase 1, PHASE2 · recruiting
- NCT07396467 — Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis · active not recruiting
- NCT06912659 — The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis W · active not recruiting
- NCT06685874 — Interstitial Lung Disease Exacerbations Study · active not recruiting
- NCT06532071 — Advanced Imaging for Pulmonary Fibrosis · Phase 2 · recruiting
Other Wissenschaftliches Institut Bethanien e.V trials
Trials by the same sponsor.
- NCT06861686 — A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores · recruiting
- NCT04527497 — Clinical Course and Treatment of COVID-19 Inpatients in Hospital · completed
- NCT04521088 — Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic · completed
- NCT04695678 — Epidemiological Multicohort Study of Latent COVID-19 Infections · completed
- NCT04093427 — Influence of an Inverse Pressure Ramp in Long-term Non-invasive Ventilation on Dyspnea in the Morning After Therapy · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06179342 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wissenschaftliches Institut Bethanien e.V
- Last refreshed: 7 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06179342.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing